TherapeuticsMD, Inc. (TXMD)
NASDAQ: TXMD · Real-Time Price · USD
1.740
+0.130 (8.07%)
At close: Dec 5, 2025, 4:00 PM EST
1.630
-0.110 (-6.32%)
After-hours: Dec 5, 2025, 5:42 PM EST
TherapeuticsMD Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 20 | 10 | 26 | 53 | 151 | 358 | |
| Market Cap Growth | 34.26% | -61.51% | -51.31% | -64.97% | -57.86% | -45.38% | |
| Enterprise Value | 20 | 12 | 24 | 148 | 241 | 527 | |
| Last Close Price | 1.74 | 0.86 | 2.25 | 5.59 | 17.77 | 60.50 | |
| PE Ratio | 275.53 | - | - | 0.47 | - | - | |
| PS Ratio | 7.19 | 5.63 | 19.79 | 0.76 | 58.71 | 5.53 | |
| PB Ratio | 0.73 | 0.36 | 0.88 | 1.51 | -1.61 | -2.89 | |
| P/TBV Ratio | 0.86 | 0.43 | 1.11 | 1.88 | - | - | |
| P/FCF Ratio | 9.74 | 13.55 | - | - | - | - | |
| P/OCF Ratio | 9.74 | 13.55 | - | - | - | - | |
| EV/Sales Ratio | 6.98 | 6.97 | 18.28 | 2.12 | 93.74 | 8.13 | |
| EV/EBITDA Ratio | - | - | - | 12.49 | - | - | |
| EV/EBIT Ratio | - | - | - | 13.89 | - | - | |
| EV/FCF Ratio | 9.43 | 16.76 | - | - | - | - | |
| Debt / Equity Ratio | 0.24 | 0.26 | 0.27 | 0.25 | -2.11 | -2.00 | |
| Debt / EBITDA Ratio | - | - | - | 0.63 | - | - | |
| Debt / FCF Ratio | 3.14 | 9.80 | - | - | - | - | |
| Asset Turnover | 0.07 | 0.04 | 0.02 | 0.54 | 0.02 | 0.29 | |
| Inventory Turnover | - | - | - | - | - | 1.61 | |
| Quick Ratio | 2.18 | 1.67 | 1.08 | 0.81 | 0.26 | 1.91 | |
| Current Ratio | 2.93 | 2.37 | 1.72 | 1.18 | 0.47 | 2.17 | |
| Return on Equity (ROE) | 0.27% | -8.16% | -23.90% | - | - | - | |
| Return on Assets (ROA) | -2.73% | -5.32% | -7.96% | 5.13% | -25.48% | -43.12% | |
| Return on Capital (ROIC) | -3.12% | -6.08% | -13.12% | 9.01% | -39.12% | -56.92% | |
| Return on Capital Employed (ROCE) | -5.10% | -10.40% | -23.40% | 24.40% | 85.80% | -126.20% | |
| Earnings Yield | 1.50% | -21.99% | -39.89% | 211.63% | -114.14% | -51.20% | |
| FCF Yield | 10.27% | 7.38% | -186.82% | -7.71% | -94.48% | -44.55% | |
| Buyback Yield / Dilution | -1.31% | -10.45% | -11.48% | -17.66% | -44.39% | -11.89% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.